• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
OIP
Click for more information
0.00% 4.3¢

ORION PETROLEUM LIMITED

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
OIP
Ann: Change of Company Name 		30/01/12 0 742
30/01/12 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  742 
CEL +
Ann: Notice of initial substantial shareholder fr 		25/01/12 10 2.9K
25/01/12 Last post  Nazzysmith Comments Created with Sketch.  10  Views Created with Sketch.  2.9K 
OIP
Ann: Quarterly Activities and Cashflow Report 		24/01/12 0 512
Healthcare SECTOR NEWS

Recce targets Indonesia for its innovative anti-infective as Indo-Aussie ties strengthen!

Read More   right-arrow Created with Sketch.
RCE
02 Oct 2024
RECCE PHARMACEUTICALS LTD
24/01/12 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  512 
CUE +
Ann: In Specie Special Dividend of CUE and OIP Sh 		24/01/12 12 3.0K
24/01/12 Last post  grahamc58 Comments Created with Sketch.  12  Views Created with Sketch.  3.0K 
OIP +
Ann: Change in substantial holding from STO 		19/01/12 0 648
19/01/12 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  648 
OIP
smh: revamped orion to focus on shale gas pros 		18/01/12 0 449
18/01/12 Last post  richrichie Comments Created with Sketch.  0  Views Created with Sketch.  449 
OIP
Ann: Completion of Petrel Energy Merger 		17/01/12 0 423
17/01/12 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  423 
OIP
Ann: Cleansing statement 		17/01/12 0 407
17/01/12 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  407 

See All Discussions arrow Created with Sketch.

Featured News

NEWS High-grade copper-gold at Mt Isa North—grab samples hit up to 30% Cu and more, with drilling set to begin
right-arrow Created with Sketch.
NEWS Drilling at May Queen intersects altered porphyritic rocks and copper sulphides, supporting a large-scale copper-gold system
right-arrow Created with Sketch.
NEWS Solar building envelope order secured for iconic WA project—discover more about this groundbreaking solar solution
right-arrow Created with Sketch.
NEWS High-grade drilling results extend Cowboy State Mine—172.4m @ 3,716 ppm TREO confirmed
right-arrow Created with Sketch.
NEWS Drilling kicks off at Goldsworthy East—30 holes planned to unlock major westward potential
right-arrow Created with Sketch.
NEWS High-grade antimony mineralization confirmed at Ricciardo with potential 1km strike length
right-arrow Created with Sketch.

Top Stories

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
SPC to merge with Original Juice Co and Nature One Dairy The Original Juice Co Ltd has set up a transaction which will see it merge with Aussie icon SPC Global and Singapore-based Nature One Dairy
Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one Cobalt Blue has released estimates for what it would take to get its proposed Kwinana refinery off the ground, seeing CapEx of $60M.
Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.

Featured News

NEWS Solar building envelope order secured for iconic WA project—discover more about this groundbreaking solar solution
right-arrow Created with Sketch.
NEWS Drilling at May Queen intersects altered porphyritic rocks and copper sulphides, supporting a large-scale copper-gold system
right-arrow Created with Sketch.
NEWS Exceptional rock chip assays at Pearl Copper Project—up to 930 g/t Ag and 10.05% Cu in Arizona
right-arrow Created with Sketch.
NEWS High-grade antimony mineralization confirmed at Ricciardo with potential 1km strike length
right-arrow Created with Sketch.
NEWS Major shallow copper-silver discovery at Junction Prospect confirmed with high-grade intercepts
right-arrow Created with Sketch.
RCE Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.